Is this page useful for you? Then, help us to keep the service working. Please have a look to our donations page ... Thanks for your help!!

PharmacoEconomics / Springer

Citation Profile [Updated: 2021-02-02 17:32:57]
5 Years H
14
Impact Factor
0.18
5 Years IF
0.2
Data available in this report

[Raw data] [50 most cited papers] [50 most relevant papers] [cites used to compute IF] [Recent citations ][Frequent citing series ] [more data in EconPapers] [trace new citations] [Missing citations? Add them now] [Incorrect content? Let us know]

Main indicators
Raw Data

 

IF AIF CIF IF5 DOC CDO CIT NCI CCU D2Y C2Y D5Y C5Y SC %SC CiY II AII
1990 0 0.09 0 0 0 0 0 0 0 0 0 0 0.04
1991 0 0.08 0 0 0 0 0 0 0 0 0 0 0.04
1992 0 0.09 0 0 0 0 0 0 0 0 0 0 0.04
1993 0 0.1 0 0 0 0 0 0 0 0 0 0 0.05
1994 0 0.12 0 0 0 0 0 0 0 0 0 0 0.06
1995 0 0.19 0 0 0 0 0 0 0 0 0 0 0.08
1996 0 0.22 0 0 0 0 0 0 0 0 0 0 0.1
1997 0 0.22 0 0 10 10 6 0 0 0 0 0 0.09
1998 0 0.26 0 0 12 22 3 0 10 10 0 0 0.12
1999 0 0.27 0.18 0 0 22 0 4 22 22 0 0 0.13
2000 0 0.32 0.03 0.05 9 31 1 1 5 12 22 1 0 0 0.14
2001 0 0.34 0 0 3 34 0 5 9 31 0 0 0.15
2002 0 0.37 0.03 0.03 0 34 0 1 6 12 34 1 0 0 0.19
2003 0 0.39 0.03 0 5 39 4 1 7 3 24 0 0 0.19
2004 0 0.44 0.03 0 1 40 1 1 8 5 17 0 0 0.2
2005 0 0.46 0.02 0 7 47 5 1 9 6 18 0 0 0.21
2006 0 0.46 0.03 0.13 62 109 60 3 12 8 16 2 1 33.3 0 0.21
2007 0.03 0.42 0.03 0.03 38 147 27 4 16 69 2 75 2 0 0 0.18
2008 0.01 0.44 0.01 0.01 22 169 121 1 17 100 1 113 1 1 100 0 0.2
2009 0 0.43 0.02 0.01 28 197 24 3 20 60 130 1 0 0 0.21
2010 0.12 0.43 0.05 0.06 33 230 35 11 31 50 6 157 10 0 0 0.18
2011 0.07 0.45 0.05 0.05 32 262 73 13 44 61 4 183 9 3 23.1 2 0.06 0.2
2012 0.15 0.45 0.11 0.14 87 349 110 38 82 65 10 153 22 4 10.5 6 0.07 0.19
2013 0.26 0.51 0.18 0.22 96 445 266 79 161 119 31 202 45 21 26.6 14 0.15 0.21
2014 0.21 0.53 0.2 0.17 123 568 269 111 272 183 38 276 47 30 27 35 0.28 0.2
2015 0.3 0.53 0.24 0.26 105 673 177 161 433 219 66 371 95 28 17.4 14 0.13 0.2
2016 0.29 0.52 0.23 0.28 145 818 140 190 623 228 66 443 124 35 18.4 10 0.07 0.19
2017 0.22 0.53 0.23 0.23 116 934 118 213 836 250 54 556 127 49 23 23 0.2 0.19
2018 0.22 0.6 0.24 0.26 128 1062 59 254 1090 261 58 585 152 34 13.4 8 0.06 0.24
2019 0.24 0.68 0.25 0.23 132 1194 38 294 1384 244 59 617 143 46 15.6 27 0.2 0.25
2020 0.18 0.99 0.21 0.2 118 1312 10 275 1659 260 46 626 127 26 9.5 7 0.06 0.38
IF: Impact Factor: C2Y / D2Y
AIF: Average Impact Factor for series in RePEc in year y
CIF: Cumulative impact factor
IF5: Impact Factor: C5Y / D5Y
DOC: Number of documents published in year y
CDO: Cumulative number of documents published until year y
CIT: Number of citations to papers published in year y
NCI: Number of citations in year y
CCU: Cumulative number of citations to papers published until year y
D2Y: Number of articles published in y-1 plus y-2
C2Y: Cites in y to articles published in y-1 plus y-2
D5Y: Number of articles published in y-1 until y-5
C5Y: Cites in y to articles published in y-1 until y-5
SC: selft citations in y to articles published in y-1 plus y-2
%SC: Percentage of selft citations in y to articles published in y-1 plus y-2
CiY: Cites in year y to documents published in year y
II: Immediacy Index: CiY / Documents.
AII: Average Immediacy Index for series in RePEc in year y
50 most cited documents in this series
#YearTitleCited
12013Consolidated Health Economic Evaluation Reporting Standards (CHEERS) Statement. (2013). Husereau, Don ; Briggs, Andrew ; Petrou, Stavros ; Drummond, Michael ; Mauskopf, Josephine ; Augustovski, Federico ; Loder, Elizabeth ; Moher, David ; Greenberg, Dan ; Carswell, Chris . In: PharmacoEconomics. RePEc:spr:pharme:v:31:y:2013:i:5:p:361-367.

Full description at Econpapers || Download paper

154
22008Conducting Discrete Choice Experiments to Inform Healthcare Decision Making. (2008). Lancsar, Emily ; Louviere, Jordan. In: PharmacoEconomics. RePEc:spr:pharme:v:26:y:2008:i:8:p:661-677.

Full description at Econpapers || Download paper

96
32014Discrete Choice Experiments in Health Economics: A Review of the Literature. (2014). Moro, Domenico ; Petrou, Stavros ; Clark, Michael ; Bekker-Grob, Esther ; Determann, Domino . In: PharmacoEconomics. RePEc:spr:pharme:v:32:y:2014:i:9:p:883-902.

Full description at Econpapers || Download paper

34
42017Discrete Choice Experiments: A Guide to Model Specification, Estimation and Software. (2017). Lancsar, Emily ; Hole, Arne ; Fiebig, Denzil. In: PharmacoEconomics. RePEc:spr:pharme:v:35:y:2017:i:7:d:10.1007_s40273-017-0506-4.

Full description at Econpapers || Download paper

30
52014Managing short-term capital flows in new central banking: unconventional monetary policy framework in Turkey. (2014). Aysan, Ahmet ; Fendoglu, Salih ; Kilinc, Mustafa . In: PharmacoEconomics. RePEc:spr:pharme:v:4:y:2014:i:1:p:45-69.

Full description at Econpapers || Download paper

27
6Effects of Reference Pricing in Pharmaceutical Markets. (2011). Miraldo, Marisa ; Galizzi, Matteo ; Ghislandi, Simone. In: PharmacoEconomics. RePEc:spr:pharme:v:29:y:2011:i:1:p:17-33.

Full description at Econpapers || Download paper

27
72012Golimumab for the Treatment of Psoriatic Arthritis. (2012). Sculpher, Mark ; EPSTEIN, DAVID ; Woolacott, Nerys ; Bojke, Laura ; Light, Kate ; Bruce, Ian ; Yang, Huiqin ; Craig, Dawn. In: PharmacoEconomics. RePEc:spr:pharme:v:30:y:2012:i:4:p:257-270.

Full description at Econpapers || Download paper

24
82014A Guide to Handling Missing Data in Cost-Effectiveness Analysis Conducted Within Randomised Controlled Trials. (2014). White, Ian ; Gomes, Manuel ; Faria, Rita ; EPSTEIN, DAVID. In: PharmacoEconomics. RePEc:spr:pharme:v:32:y:2014:i:12:p:1157-1170.

Full description at Econpapers || Download paper

23
92015Savings in Medical Expenditures Associated with Reductions in Body Mass Index Among US Adults with Obesity, by Diabetes Status. (2015). Cawley, John ; Biener, Adam ; Wintfeld, Neil ; Meyerhoefer, Chad ; Hammer, Mette . In: PharmacoEconomics. RePEc:spr:pharme:v:33:y:2015:i:7:p:707-722.

Full description at Econpapers || Download paper

20
102015The Economic Costs of Type 2 Diabetes: A Global Systematic Review. (2015). Seuring, Till ; Suhrcke, Marc ; Archangelidi, Olga . In: PharmacoEconomics. RePEc:spr:pharme:v:33:y:2015:i:8:p:811-831.

Full description at Econpapers || Download paper

19
112019Discrete Choice Experiments in Health Economics: Past, Present and Future. (2019). Soekhai, Vikas ; Vass, Caroline M ; Ellis, Alan R ; Bekker-Grob, Esther W. In: PharmacoEconomics. RePEc:spr:pharme:v:37:y:2019:i:2:d:10.1007_s40273-018-0734-2.

Full description at Econpapers || Download paper

17
122014Reconceptualising the External Validity of Discrete Choice Experiments. (2014). Swait, Joffre ; Lancsar, Emily. In: PharmacoEconomics. RePEc:spr:pharme:v:32:y:2014:i:10:p:951-965.

Full description at Econpapers || Download paper

16
132014Monetary policy challenges: how central banks changed their modus operandi. (2014). Giorgio, Giorgio . In: PharmacoEconomics. RePEc:spr:pharme:v:4:y:2014:i:1:p:25-43.

Full description at Econpapers || Download paper

15
142016EuroQol Protocols for Time Trade-Off Valuation of Health Outcomes. (2016). Shah, Koonal ; Luo, Nan ; Ramosgoi, Juan M ; Rand-Hendriksen, Kim ; Oppe, Mark. In: PharmacoEconomics. RePEc:spr:pharme:v:34:y:2016:i:10:d:10.1007_s40273-016-0404-1.

Full description at Econpapers || Download paper

15
152014The Value of a QALY: Individual Willingness to Pay for Health Gains Under Risk. (2014). van Exel, Job ; Brouwer, Werner ; Bobinac, Ana . In: PharmacoEconomics. RePEc:spr:pharme:v:32:y:2014:i:1:p:75-86.

Full description at Econpapers || Download paper

14
162014Capital’s grabbing hand? A cross-industry analysis of the decline of the labor share in OECD countries. (2014). Bassanini, Andrea ; Manfredi, Thomas . In: PharmacoEconomics. RePEc:spr:pharme:v:4:y:2014:i:1:p:3-30.

Full description at Econpapers || Download paper

13
172014Japan’s monetary policy in a challenging environment. (2014). Shirai, Sayuri. In: PharmacoEconomics. RePEc:spr:pharme:v:4:y:2014:i:1:p:3-24.

Full description at Econpapers || Download paper

12
182015Disinvestment and Value-Based Purchasing Strategies for Pharmaceuticals: An International Review. (2015). Viney, Rosalie ; Sermet, Catherine ; Parkinson, Bonny ; Elshaug, Adam ; Lopert, Ruth ; Pearson, Sallie-Anne ; Choudhury, Moni ; Garner, Sarah ; Godman, Brian ; Crausaz, Steffan ; Clement, Fiona . In: PharmacoEconomics. RePEc:spr:pharme:v:33:y:2015:i:9:p:905-924.

Full description at Econpapers || Download paper

12
192014Assessing the Value of Healthcare Interventions Using Multi-Criteria Decision Analysis: A Review of the Literature. (2014). Neasham, David ; Lanitis, Tereza ; Orfanos, Panagiotis ; Marsh, Kevin ; Caro, Jaime . In: PharmacoEconomics. RePEc:spr:pharme:v:32:y:2014:i:4:p:345-365.

Full description at Econpapers || Download paper

12
20Overview of Parametric Survival Analysis for Health-Economic Applications. (2013). Kreif, Noemi ; Benedict, Agnes ; Muszbek, Noemi ; Ishak, K.. In: PharmacoEconomics. RePEc:spr:pharme:v:31:y:2013:i:8:p:663-675.

Full description at Econpapers || Download paper

12
212013Operationalizing Value-Based Pricing of Medicines. (2013). Towse, Adrian ; Devlin, Nancy ; Sussex, Jon . In: PharmacoEconomics. RePEc:spr:pharme:v:31:y:2013:i:1:p:1-10.

Full description at Econpapers || Download paper

11
222016Health, Health-Related Quality of Life, and Quality of Life: What is the Difference?. (2016). Brazier, John ; Karimi, Milad. In: PharmacoEconomics. RePEc:spr:pharme:v:34:y:2016:i:7:d:10.1007_s40273-016-0389-9.

Full description at Econpapers || Download paper

11
232015Reimbursement Decisions for Pharmaceuticals in Sweden: The Impact of Disease Severity and Cost Effectiveness. (2015). Svensson, Mikael ; Nilsson, Fredrik ; Arnberg, Karl . In: PharmacoEconomics. RePEc:spr:pharme:v:33:y:2015:i:11:p:1229-1236.

Full description at Econpapers || Download paper

11
242014Effects of additional monetary tightening on exchange rates. (2014). Oduncu, Arif ; Akcelik, Yasin ; Taskin, Temel ; Ermisoglu, Ergun . In: PharmacoEconomics. RePEc:spr:pharme:v:4:y:2014:i:1:p:71-79.

Full description at Econpapers || Download paper

11
252014How to Estimate Productivity Costs in Economic Evaluations. (2014). Brouwer, Werner ; Krol, Marieke . In: PharmacoEconomics. RePEc:spr:pharme:v:32:y:2014:i:4:p:335-344.

Full description at Econpapers || Download paper

10
262014Preferences for Oral Anticoagulants in Atrial Fibrillation: a Best–Best Discrete Choice Experiment. (2014). Lancsar, Emily ; Ghijben, Peter ; Zavarsek, Silva . In: PharmacoEconomics. RePEc:spr:pharme:v:32:y:2014:i:11:p:1115-1127.

Full description at Econpapers || Download paper

10
272015A Review of the Development and Application of Generic Multi-Attribute Utility Instruments for Paediatric Populations. (2015). Chen, Gang ; Ratcliffe, Julie. In: PharmacoEconomics. RePEc:spr:pharme:v:33:y:2015:i:10:p:1013-1028.

Full description at Econpapers || Download paper

10
282016Value-Based Assessment of New Medical Technologies: Towards a Robust Methodological Framework for the Application of Multiple Criteria Decision Analysis in the Context of Health Technology Assessment. (2016). Kanavos, Panos ; Angelis, Aris. In: PharmacoEconomics. RePEc:spr:pharme:v:34:y:2016:i:5:d:10.1007_s40273-015-0370-z.

Full description at Econpapers || Download paper

10
292012Contribution of Pharmaceutical Innovation to Longevity Growth in Germany and France, 2001–7. (2012). Lichtenberg, Frank. In: PharmacoEconomics. RePEc:spr:pharme:v:30:y:2012:i:3:p:197-211.

Full description at Econpapers || Download paper

10
302006Impacts of Cost Containment Strategies on Pharmaceutical Expenditures of the National Health Insurance in Taiwan, 1996–2003. (2006). Liu, Chien-Hsiang ; Lee, Yue-Chune ; Huang, Yu-Tung ; Chen, Sun-Bing ; Yang, Ming-Chin . In: PharmacoEconomics. RePEc:spr:pharme:v:24:y:2006:i:9:p:891-902.

Full description at Econpapers || Download paper

10
31The Valuation of Informal Care in Cost-of-Illness Studies: A Systematic Review. (2017). oliva, juan ; Oliva-Moreno, Juan ; del Pozo-Rubio, Raul ; Pea-Longobardo, Luz Maria ; Trapero-Bertran, Marta . In: PharmacoEconomics. RePEc:spr:pharme:v:35:y:2017:i:3:d:10.1007_s40273-016-0468-y.

Full description at Econpapers || Download paper

9
322017International Regulations and Recommendations for Utility Data for Health Technology Assessment. (2017). Rowen, Donna ; Hout, Ben ; Chevrou-Severac, Helene ; Zouraq, Ismail Azzabi. In: PharmacoEconomics. RePEc:spr:pharme:v:35:y:2017:i:1:d:10.1007_s40273-017-0544-y.

Full description at Econpapers || Download paper

9
332012Erratum to Systematic Reviewof the Cost and Cost Effectiveness of Treatment for Multidrug-Resistant Tuberculosis. (2012). Fitzpatrick, C. ; Floyd, K.. In: PharmacoEconomics. RePEc:spr:pharme:v:30:y:2012:i:1:p:81-81.

Full description at Econpapers || Download paper

9
342013Unravelling Drug Reimbursement Outcomes: A Comparative Study of the Role of Pharmacoeconomic Evidence in Dutch and Swedish Reimbursement Decision Making. (2013). Boer, Anthonius ; Franken, Margreet ; Koopmanschap, Marc ; Nilsson, Fredrik ; Sandmann, Frank . In: PharmacoEconomics. RePEc:spr:pharme:v:31:y:2013:i:9:p:781-797.

Full description at Econpapers || Download paper

9
352011Unit Costs for Delivery of Antiretroviral Treatment and Prevention of Mother-to-Child Transmission of HIV. (2011). Galarraga, Omar ; Figueroa-Lara, Alejandro ; Yared Santa-Ana-Tellez, ; Wirtz, Veronika ; Viisainen, Kirsi ; Coulibaly, Ibrahima ; Korenromp, Eline ; Medina-Lara, Antonieta . In: PharmacoEconomics. RePEc:spr:pharme:v:29:y:2011:i:7:p:579-599.

Full description at Econpapers || Download paper

9
362012A Systematic Review of the Cost and Cost Effectiveness of Treatment for Multidrug-Resistant Tuberculosis. (2012). Fitzpatrick, Christopher ; Floyd, Katherine . In: PharmacoEconomics. RePEc:spr:pharme:v:30:y:2012:i:1:p:63-80.

Full description at Econpapers || Download paper

9
372013How to Include Informal Care in Economic Evaluations. (2013). van Exel, Job ; Brouwer, Werner ; Hoefman, Renske . In: PharmacoEconomics. RePEc:spr:pharme:v:31:y:2013:i:12:p:1105-1119.

Full description at Econpapers || Download paper

8
382015Valuing QALYs in Relation to Equity Considerations Using a Discrete Choice Experiment. (2015). van Exel, Job ; Brouwer, Werner ; Bobinac, Ana ; Wetering, Liesbet . In: PharmacoEconomics. RePEc:spr:pharme:v:33:y:2015:i:12:p:1289-1300.

Full description at Econpapers || Download paper

8
392011Calibrating Models in Economic Evaluation. (2011). Karnon, Jonathan ; Vanni, Tazio . In: PharmacoEconomics. RePEc:spr:pharme:v:29:y:2011:i:1:p:51-62.

Full description at Econpapers || Download paper

8
402006The Effect of Using Newer Drugs on Admissions of Elderly Americans to Hospitals and Nursing Homes: State-level Evidence from 1997 to 2003. (2006). Lichtenberg, Frank. In: PharmacoEconomics. RePEc:spr:pharme:v:24:y:2006:i:3:p:5-25.

Full description at Econpapers || Download paper

8
412014The probability of default in Russian banking. (2014). Karminsky, Alexander ; Kostrov, Alexander . In: PharmacoEconomics. RePEc:spr:pharme:v:4:y:2014:i:1:p:81-98.

Full description at Econpapers || Download paper

8
422011Calibrating Models in Economic Evaluation. (2011). Foss, Anna ; Edmunds, W. ; Vanni, Tazio ; Legood, Rosa ; White, Richard ; Karnon, Jonathan ; Madan, Jason . In: PharmacoEconomics. RePEc:spr:pharme:v:29:y:2011:i:1:p:35-49.

Full description at Econpapers || Download paper

8
432015Value-Based Reimbursement Decisions for Orphan Drugs: A Scoping Review and Decision Framework. (2015). McCabe, Christopher ; Stafinski, Tania ; Paulden, Mike ; Menon, Devidas . In: PharmacoEconomics. RePEc:spr:pharme:v:33:y:2015:i:3:p:255-269.

Full description at Econpapers || Download paper

8
442018German Value Set for the EQ-5D-5L. (2018). Ludwig, Kristina ; Greiner, Wolfgang ; von der Schulenburg, J-Matthias Graf ; J-Matthias Graf von der Schulenburg, . In: PharmacoEconomics. RePEc:spr:pharme:v:36:y:2018:i:6:d:10.1007_s40273-018-0615-8.

Full description at Econpapers || Download paper

8
45The Impact of the Urban Resident Basic Medical Insurance on Health Services Utilisation in China. (2014). Chen, Gang ; Xu, Fei ; Liu, Gordon. In: PharmacoEconomics. RePEc:spr:pharme:v:32:y:2014:i:3:p:277-292.

Full description at Econpapers || Download paper

8
462015Does Including Informal Care in Economic Evaluations Matter? A Systematic Review of Inclusion and Impact of Informal Care in Cost-Effectiveness Studies. (2015). van Exel, Job ; Krol, Marieke ; Papenburg, Joce . In: PharmacoEconomics. RePEc:spr:pharme:v:33:y:2015:i:2:p:123-135.

Full description at Econpapers || Download paper

8
472014Self-employment against employment or unemployment: Markov transitions across the business cycle. (2014). Constant, Amelie ; Zimmermann, Klaus. In: PharmacoEconomics. RePEc:spr:pharme:v:4:y:2014:i:1:p:51-87.

Full description at Econpapers || Download paper

7
482014Can the Real Opportunity Cost Stand Up: Displaced Services, the Straw Man Outside the Room. (2014). Pekarsky, Brita ; Eckermann, Simon. In: PharmacoEconomics. RePEc:spr:pharme:v:32:y:2014:i:4:p:319-325.

Full description at Econpapers || Download paper

7
492016Biosimilars: How Can Payers Get Long-Term Savings?. (2016). Towse, Adrian ; Berdud, Mikel ; Mestre-Ferrandiz, Jorge. In: PharmacoEconomics. RePEc:spr:pharme:v:34:y:2016:i:6:d:10.1007_s40273-015-0380-x.

Full description at Econpapers || Download paper

7
502008Generic Entry, Reformulations and Promotion of SSRIs in the US. (2008). Koss, Catherine ; Frank, Richard ; Donohue, Julie ; Huskamp, Haiden ; Berndt, Ernst . In: PharmacoEconomics. RePEc:spr:pharme:v:26:y:2008:i:7:p:603-616.

Full description at Econpapers || Download paper

7
50 most relevant documents in this series (papers most cited in the last two years)
#YearTitleCited
12008Conducting Discrete Choice Experiments to Inform Healthcare Decision Making. (2008). Lancsar, Emily ; Louviere, Jordan. In: PharmacoEconomics. RePEc:spr:pharme:v:26:y:2008:i:8:p:661-677.

Full description at Econpapers || Download paper

32
22013Consolidated Health Economic Evaluation Reporting Standards (CHEERS) Statement. (2013). Husereau, Don ; Briggs, Andrew ; Petrou, Stavros ; Drummond, Michael ; Mauskopf, Josephine ; Augustovski, Federico ; Loder, Elizabeth ; Moher, David ; Greenberg, Dan ; Carswell, Chris . In: PharmacoEconomics. RePEc:spr:pharme:v:31:y:2013:i:5:p:361-367.

Full description at Econpapers || Download paper

29
32017Discrete Choice Experiments: A Guide to Model Specification, Estimation and Software. (2017). Lancsar, Emily ; Hole, Arne ; Fiebig, Denzil. In: PharmacoEconomics. RePEc:spr:pharme:v:35:y:2017:i:7:d:10.1007_s40273-017-0506-4.

Full description at Econpapers || Download paper

25
42019Discrete Choice Experiments in Health Economics: Past, Present and Future. (2019). Soekhai, Vikas ; Vass, Caroline M ; Ellis, Alan R ; Bekker-Grob, Esther W. In: PharmacoEconomics. RePEc:spr:pharme:v:37:y:2019:i:2:d:10.1007_s40273-018-0734-2.

Full description at Econpapers || Download paper

15
52014Discrete Choice Experiments in Health Economics: A Review of the Literature. (2014). Moro, Domenico ; Petrou, Stavros ; Clark, Michael ; Bekker-Grob, Esther ; Determann, Domino . In: PharmacoEconomics. RePEc:spr:pharme:v:32:y:2014:i:9:p:883-902.

Full description at Econpapers || Download paper

13
62014Reconceptualising the External Validity of Discrete Choice Experiments. (2014). Swait, Joffre ; Lancsar, Emily. In: PharmacoEconomics. RePEc:spr:pharme:v:32:y:2014:i:10:p:951-965.

Full description at Econpapers || Download paper

10
72016Health, Health-Related Quality of Life, and Quality of Life: What is the Difference?. (2016). Brazier, John ; Karimi, Milad. In: PharmacoEconomics. RePEc:spr:pharme:v:34:y:2016:i:7:d:10.1007_s40273-016-0389-9.

Full description at Econpapers || Download paper

8
82015Savings in Medical Expenditures Associated with Reductions in Body Mass Index Among US Adults with Obesity, by Diabetes Status. (2015). Cawley, John ; Biener, Adam ; Wintfeld, Neil ; Meyerhoefer, Chad ; Hammer, Mette . In: PharmacoEconomics. RePEc:spr:pharme:v:33:y:2015:i:7:p:707-722.

Full description at Econpapers || Download paper

7
92014Managing short-term capital flows in new central banking: unconventional monetary policy framework in Turkey. (2014). Aysan, Ahmet ; Fendoglu, Salih ; Kilinc, Mustafa . In: PharmacoEconomics. RePEc:spr:pharme:v:4:y:2014:i:1:p:45-69.

Full description at Econpapers || Download paper

7
102014A Guide to Handling Missing Data in Cost-Effectiveness Analysis Conducted Within Randomised Controlled Trials. (2014). White, Ian ; Gomes, Manuel ; Faria, Rita ; EPSTEIN, DAVID. In: PharmacoEconomics. RePEc:spr:pharme:v:32:y:2014:i:12:p:1157-1170.

Full description at Econpapers || Download paper

7
112015The Economic Costs of Type 2 Diabetes: A Global Systematic Review. (2015). Seuring, Till ; Suhrcke, Marc ; Archangelidi, Olga . In: PharmacoEconomics. RePEc:spr:pharme:v:33:y:2015:i:8:p:811-831.

Full description at Econpapers || Download paper

6
122018German Value Set for the EQ-5D-5L. (2018). Ludwig, Kristina ; Greiner, Wolfgang ; von der Schulenburg, J-Matthias Graf ; J-Matthias Graf von der Schulenburg, . In: PharmacoEconomics. RePEc:spr:pharme:v:36:y:2018:i:6:d:10.1007_s40273-018-0615-8.

Full description at Econpapers || Download paper

6
132011Effects of Reference Pricing in Pharmaceutical Markets. (2011). Miraldo, Marisa ; Galizzi, Matteo ; Ghislandi, Simone. In: PharmacoEconomics. RePEc:spr:pharme:v:29:y:2011:i:1:p:17-33.

Full description at Econpapers || Download paper

6
142015A Review of the Development and Application of Generic Multi-Attribute Utility Instruments for Paediatric Populations. (2015). Chen, Gang ; Ratcliffe, Julie. In: PharmacoEconomics. RePEc:spr:pharme:v:33:y:2015:i:10:p:1013-1028.

Full description at Econpapers || Download paper

6
152017The Valuation of Informal Care in Cost-of-Illness Studies: A Systematic Review. (2017). oliva, juan ; Oliva-Moreno, Juan ; del Pozo-Rubio, Raul ; Pea-Longobardo, Luz Maria ; Trapero-Bertran, Marta . In: PharmacoEconomics. RePEc:spr:pharme:v:35:y:2017:i:3:d:10.1007_s40273-016-0468-y.

Full description at Econpapers || Download paper

5
162017International Regulations and Recommendations for Utility Data for Health Technology Assessment. (2017). Rowen, Donna ; Hout, Ben ; Chevrou-Severac, Helene ; Zouraq, Ismail Azzabi. In: PharmacoEconomics. RePEc:spr:pharme:v:35:y:2017:i:1:d:10.1007_s40273-017-0544-y.

Full description at Econpapers || Download paper

5
172018Differential Pricing of Pharmaceuticals: Theory, Evidence and Emerging Issues. (2018). Danzon, Patricia. In: PharmacoEconomics. RePEc:spr:pharme:v:36:y:2018:i:12:d:10.1007_s40273-018-0696-4.

Full description at Econpapers || Download paper

5
182014How to Estimate Productivity Costs in Economic Evaluations. (2014). Brouwer, Werner ; Krol, Marieke . In: PharmacoEconomics. RePEc:spr:pharme:v:32:y:2014:i:4:p:335-344.

Full description at Econpapers || Download paper

5
192015A Practical Guide to Value of Information Analysis. (2015). Wilson, Edward . In: PharmacoEconomics. RePEc:spr:pharme:v:33:y:2015:i:2:p:105-121.

Full description at Econpapers || Download paper

5
202013Reference Pricing and Price Negotiations for Innovative New Drugs. (2013). Gandjour, Afschin. In: PharmacoEconomics. RePEc:spr:pharme:v:31:y:2013:i:1:p:11-14.

Full description at Econpapers || Download paper

5
212016EuroQol Protocols for Time Trade-Off Valuation of Health Outcomes. (2016). Shah, Koonal ; Luo, Nan ; Ramosgoi, Juan M ; Rand-Hendriksen, Kim ; Oppe, Mark. In: PharmacoEconomics. RePEc:spr:pharme:v:34:y:2016:i:10:d:10.1007_s40273-016-0404-1.

Full description at Econpapers || Download paper

5
222016From Good to Better: New Dutch Guidelines for Economic Evaluations in Healthcare. (2016). Brouwer, Werner ; Knies, Saskia ; Versteegh, Matthijs . In: PharmacoEconomics. RePEc:spr:pharme:v:34:y:2016:i:11:d:10.1007_s40273-016-0431-y.

Full description at Econpapers || Download paper

5
232016Value-Based Assessment of New Medical Technologies: Towards a Robust Methodological Framework for the Application of Multiple Criteria Decision Analysis in the Context of Health Technology Assessment. (2016). Kanavos, Panos ; Angelis, Aris. In: PharmacoEconomics. RePEc:spr:pharme:v:34:y:2016:i:5:d:10.1007_s40273-015-0370-z.

Full description at Econpapers || Download paper

5
242015Costs to Health Services and the Patient of Treating Tuberculosis: A Systematic Literature Review. (2015). Laurence, Yoko ; Vassall, Anna ; Griffiths, Ulla . In: PharmacoEconomics. RePEc:spr:pharme:v:33:y:2015:i:9:p:939-955.

Full description at Econpapers || Download paper

4
252016Using Best–Worst Scaling to Investigate Preferences in Health Care. (2016). Hollin, Ilene L ; Cheung, Kei Long ; Hiligsmann, Mickael ; Silvia, ; Bridges, John F ; Janssen, Ellen M. In: PharmacoEconomics. RePEc:spr:pharme:v:34:y:2016:i:12:d:10.1007_s40273-016-0429-5.

Full description at Econpapers || Download paper

4
262018Estimating Drug Costs: How do Manufacturer Net Prices Compare with Other Common US Price References?. (2018). Mattingly, Joseph T ; Perfetto, Eleanor M ; Onwudiwe, Nneka C ; Slejko, Julia F ; Levy, Joseph F. In: PharmacoEconomics. RePEc:spr:pharme:v:36:y:2018:i:9:d:10.1007_s40273-018-0667-9.

Full description at Econpapers || Download paper

4
272011Calibrating Models in Economic Evaluation. (2011). Foss, Anna ; Edmunds, W. ; Vanni, Tazio ; Legood, Rosa ; White, Richard ; Karnon, Jonathan ; Madan, Jason . In: PharmacoEconomics. RePEc:spr:pharme:v:29:y:2011:i:1:p:35-49.

Full description at Econpapers || Download paper

4
282014Estimating QALY Gains in Applied Studies: A Review of Cost-Utility Analyses Published in 2010. (2014). Movik, Espen ; Hamidi, Vida ; Wisloff, Torbjorn ; Klemp, Marianne ; Olsen, Jan ; Hagen, Gunhild . In: PharmacoEconomics. RePEc:spr:pharme:v:32:y:2014:i:4:p:367-375.

Full description at Econpapers || Download paper

4
292018Estimating the Reference Incremental Cost-Effectiveness Ratio for the Australian Health System. (2018). Edney, Laura Catherine ; Karnon, Jonathan ; Cheng, Terence Chai ; Ali, Hossein Haji. In: PharmacoEconomics. RePEc:spr:pharme:v:36:y:2018:i:2:d:10.1007_s40273-017-0585-2.

Full description at Econpapers || Download paper

4
302015Economic Evaluations with Agent-Based Modelling: An Introduction. (2015). He, Tianhua ; Chhatwal, Jagpreet . In: PharmacoEconomics. RePEc:spr:pharme:v:33:y:2015:i:5:p:423-433.

Full description at Econpapers || Download paper

4
312015Valuing QALYs in Relation to Equity Considerations Using a Discrete Choice Experiment. (2015). van Exel, Job ; Brouwer, Werner ; Bobinac, Ana ; Wetering, Liesbet . In: PharmacoEconomics. RePEc:spr:pharme:v:33:y:2015:i:12:p:1289-1300.

Full description at Econpapers || Download paper

4
322015The Epidemiology of Obesity: A Big Picture. (2015). Hu, Frank ; Hruby, Adela . In: PharmacoEconomics. RePEc:spr:pharme:v:33:y:2015:i:7:p:673-689.

Full description at Econpapers || Download paper

4
332011Calibrating Models in Economic Evaluation. (2011). Karnon, Jonathan ; Vanni, Tazio . In: PharmacoEconomics. RePEc:spr:pharme:v:29:y:2011:i:1:p:51-62.

Full description at Econpapers || Download paper

4
342014Preferences for Oral Anticoagulants in Atrial Fibrillation: a Best–Best Discrete Choice Experiment. (2014). Lancsar, Emily ; Ghijben, Peter ; Zavarsek, Silva . In: PharmacoEconomics. RePEc:spr:pharme:v:32:y:2014:i:11:p:1115-1127.

Full description at Econpapers || Download paper

4
352017Measuring Care-Related Quality of Life of Caregivers for Use in Economic Evaluations: CarerQol Tariffs for Australia, Germany, Sweden, UK, and US. (2017). van Exel, Job ; Hoefman, Renske J. In: PharmacoEconomics. RePEc:spr:pharme:v:35:y:2017:i:4:d:10.1007_s40273-016-0477-x.

Full description at Econpapers || Download paper

4
362017The Implementation of Managed Entry Agreements in Central and Eastern Europe: Findings and Implications. (2017). Loblova, Olga ; Ferrario, Alessandra ; Kanavos, Panos ; Laidmae, Erki ; Haycox, Alan ; Jakupi, Arianit ; Voncina, Luka ; Hoxha, Iris ; Tomek, Dominik ; Greiit-Kuprijanov, Ieva ; Pomorski, Maciej ; Furst, Jurij ; Petrova, Guenka ; Dimitrova, Maria ; Novakovic, Tanja ; Danko, David ; Meshkov, Dmitry ; Ati, Tarik ; Markovic-Pekovic, Vanda ; Bochenek, Tomasz ; Godman, Brian ; Mardare, Ileana ; Arja, Dina ; Bonanno, Patricia Vella. In: PharmacoEconomics. RePEc:spr:pharme:v:35:y:2017:i:12:d:10.1007_s40273-017-0559-4.

Full description atDisinvestment and Value-Based Purchasing Strategies for Pharmaceuticals: An International Review. (2015). Viney, Rosalie ; Sermet, Catherine ; Parkinson, Bonny ; Elshaug, Adam ; Lopert, Ruth ; Pearson, Sallie-Anne ; Choudhury, Moni ; Garner, Sarah ; Godman, Brian ; Crausaz, Steffan ; Clement, Fiona . In: PharmacoEconomics. RePEc:spr:pharme:v:33:y:2015:i:9:p:905-924.

Full description at Econpapers || Download paper

4
382018Is EQ-5D-5L Better Than EQ-5D-3L? A Head-to-Head Comparison of Descriptive Systems and Value Sets from Seven Countries. (2018). Janssen, Mathieu F ; Luo, Nan ; Bonsel, Gouke J. In: PharmacoEconomics. RePEc:spr:pharme:v:36:y:2018:i:6:d:10.1007_s40273-018-0623-8.

Full description at Econpapers || Download paper

4
392018Discounting in Economic Evaluations. (2018). Claxton, Karl ; Attema, Arthur. In: PharmacoEconomics. RePEc:spr:pharme:v:36:y:2018:i:7:d:10.1007_s40273-018-0672-z.

Full description at Econpapers || Download paper

4
402017Does the Public Prefer Health Gain for Cancer Patients? A Systematic Review of Public Views on Cancer and its Characteristics. (2017). Morrell, Liz ; Barker, Richard ; Rees, Sian ; Wordsworth, Sarah . In: PharmacoEconomics. RePEc:spr:pharme:v:35:y:2017:i:8:d:10.1007_s40273-017-0511-7.

Full description at Econpapers || Download paper

4
412016The Impact of Different DCE-Based Approaches When Anchoring Utility Scores. (2016). Viney, Rosalie ; Mulhern, Brendan ; Norman, Richard. In: PharmacoEconomics. RePEc:spr:pharme:v:34:y:2016:i:8:d:10.1007_s40273-016-0399-7.

Full description at Econpapers || Download paper

3
422018Utility Values for Health States in Ireland: A Value Set for the EQ-5D-5L. (2018). Hobbins, Anna ; Oneill, Ciaran ; Ramos, Juan Manuel ; Devlin, Nancy ; Shah, Koonal ; Kelleher, Dan ; Barry, Luke . In: PharmacoEconomics. RePEc:spr:pharme:v:36:y:2018:i:11:d:10.1007_s40273-018-0690-x.

Full description at Econpapers || Download paper

3
432017Validation of the Economic and Health Outcomes Model of Type 2 Diabetes Mellitus (ECHO-T2DM). (2017). Johansen, Pierre ; Willis, Michael ; Asseburg, Christian ; Nilsson, Andreas. In: PharmacoEconomics. RePEc:spr:pharme:v:35:y:2017:i:3:d:10.1007_s40273-016-0471-3.

Full description at Econpapers || Download paper

3
442015Does Including Informal Care in Economic Evaluations Matter? A Systematic Review of Inclusion and Impact of Informal Care in Cost-Effectiveness Studies. (2015). van Exel, Job ; Krol, Marieke ; Papenburg, Joce . In: PharmacoEconomics. RePEc:spr:pharme:v:33:y:2015:i:2:p:123-135.

Full description at Econpapers || Download paper

3
452014The Value of a QALY: Individual Willingness to Pay for Health Gains Under Risk. (2014). van Exel, Job ; Brouwer, Werner ; Bobinac, Ana . In: PharmacoEconomics. RePEc:spr:pharme:v:32:y:2014:i:1:p:75-86.

Full description at Econpapers || Download paper

3
462019One Method, Many Methodological Choices: A Structured Review of Discrete-Choice Experiments for Health State Valuation. (2019). Mulhern, Brendan ; Viney, Rosalie ; Street, Deborah J ; Norman, Richard. In: PharmacoEconomics. RePEc:spr:pharme:v:37:y:2019:i:1:d:10.1007_s40273-018-0714-6.

Full description at Econpapers || Download paper

3
472014Innovation for economic performance: the case of Latin American firms. (2014). Arias-Ortiz, Elena ; Zuiga, Pluvia ; Crespi, Gustavo ; Vargas, Fernando ; Tacsir, Ezequiel. In: PharmacoEconomics. RePEc:spr:pharme:v:4:y:2014:i:1:p:31-50.

Full description at Econpapers || Download paper

3
482014Capital’s grabbing hand? A cross-industry analysis of the decline of the labor share in OECD countries. (2014). Bassanini, Andrea ; Manfredi, Thomas . In: PharmacoEconomics. RePEc:spr:pharme:v:4:y:2014:i:1:p:3-30.

Full description at Econpapers || Download paper

3
492013Overview of Parametric Survival Analysis for Health-Economic Applications. (2013). Kreif, Noemi ; Benedict, Agnes ; Muszbek, Noemi ; Ishak, K.. In: PharmacoEconomics. RePEc:spr:pharme:v:31:y:2013:i:8:p:663-675.

Full description at Econpapers || Download paper

3
502014Assessing the Value of Healthcare Interventions Using Multi-Criteria Decision Analysis: A Review of the Literature. (2014). Neasham, David ; Lanitis, Tereza ; Orfanos, Panagiotis ; Marsh, Kevin ; Caro, Jaime . In: PharmacoEconomics. RePEc:spr:pharme:v:32:y:2014:i:4:p:345-365.

Full description at Econpapers || Download paper

3
Citing documents used to compute impact factor: 46
YearTitle
2020Economic evaluation of culprit lesion only PCI vs. immediate multivessel PCI in acute myocardial infarction complicated by cardiogenic shock: the CULPRIT-SHOCK trial. (2020). Quayyum, Zahidul ; Rana, Dikshyanta ; Briggs, Andrew ; Robles-Zurita, Jose Antonio ; Thiele, Holger ; Waha-Thiele, Suzanne ; Desch, Steffen ; Zeymer, Uwe ; Oldroyd, Keith G. In: The European Journal of Health Economics. RePEc:spr:eujhec:v:21:y:2020:i:8:d:10.1007_s10198-020-01235-3.

Full description at Econpapers || Download Out-of-Pocket Cancer Care Costs and Value Frameworks: A Case Study in a Community Oncology Practice with a Financial Navigator Program. (2020). Leopold, Christine ; Wagner, Anita K ; Gilkey, Melissa ; Rosenberg, Carol ; Araujo-Lane, Carina. In: PharmacoEconomics - Open. RePEc:spr:pharmo:v:4:y:2020:i:2:d:10.1007_s41669-019-0170-z.

Full description at Econpapers || Download paper

2020EQ-5D-5L Bulgarian population norms. (2020). Golicki, Dominik ; Vekov, Toni ; Djambazov, Slaveyko ; Encheva, Marta. In: The European Journal of Health Economics. RePEc:spr:eujhec:v:21:y:2020:i:8:d:10.1007_s10198-020-01225-5.

Full description at Econpapers || Download paper

2020A two-step procedure to generate utilities for the Infant health-related Quality of life Instrument (IQI). (2020). , Paul ; Vermeulen, Karin M ; Dainelli, Livia ; Detzel, Patrick ; Jabrayilov, Ruslan. In: PLOS ONE. RePEc:plo:pone00:0230852.

Full description at Econpapers || Download paper

2020A new tool for creating personal and social EQ-5D-5L value sets, including valuing ‘dead’. (2020). Devlin, Nancy ; Ombler, Franz ; Hansen, Paul ; Sullivan, Trudy ; Derrett, Sarah. In: Social Science & Medicine. RePEc:eee:socmed:v:246:y:2020:i:c:s0277953619307026.

Full description at Econpapers || Download paper

2020Examining the transnational health preferences of a group of Eastern European migrants relative to a European host population using the EQ-5D-5L. (2020). O'Neill, Stephen ; Hobbins, Anna ; Barry, Luke ; Kelleher, Dan ; Doherty, Edel. In: Social Science & Medicine. RePEc:eee:socmed:v:246:y:2020:i:c:s0277953620300204.

Full description at Econpapers || Download paper

2020An exploration of methods for obtaining 0 = dead anchors for latent scale EQ-5D-Y values. (2020). Devlin, Nancy ; Kreimeier, Simone ; Ramos-Goi, Juan Manuel ; Shah, Koonal K. In: The European Journal of Health Economics. RePEc:spr:eujhec:v:21:y:2020:i:7:d:10.1007_s10198-020-01205-9.

Full description at Econpapers || Download paper

2020Do people with private health insurance attach a higher value to health than those without insurance? Results from an EQ-5D-5 L valuation study in Ireland. (2020). Shah, Koonal ; Devlin, Nancy ; Oneill, Ciaran ; Ramos, Juan Manuel ; Kelleher, Dan ; Barry, Luke ; Hobbins, Anna P. In: Health Policy. RePEc:eee:hepoli:v:124:y:2020:i:6:p:639-646.

Full description at Econpapers || Download paper

2020Experience-Based Swedish TTO and VAS Value Sets for EQ-5D-5L Health States. (2020). Gerdtham, Ulf-G. ; Leidl, Reiner ; Ulf-G. Gerdtham, ; Ulf- G. Gerdtham, ; Teni, Fitsum Sebsibe ; Burstrom, Kristina ; Henriksson, Martin ; Rolfson, Ola ; Helgesson, Gert. In: PharmacoEconomics. RePEc:spr:pharme:v:38:y:2020:i:8:d:10.1007_s40273-020-00905-7.

Full description at Econpapers || Download paper

2020Does the EVA valuation model explain the market value of equity better under changing required return than constant required return?. (2020). Behera, Sujata. In: Financial Innovation. RePEc:spr:fininn:v:6:y:2020:i:1:d:10.1186_s40854-019-0167-8.

Full description at Econpapers || Download paper

2020Implications of Low Carbon City Sustainability Strategies for 2050. (2020). Levin, Gregor ; Weinzettel, Jan ; Harris, Steve. In: Sustainability. RePEc:gam:jsusta:v:12:y:2020:i:13:p:5417-:d:380420.

Full description at Econpapers || Download paper

2020Costs and benefits of interventions aimed at major infectious disease threats: lessons from the literature. (2020). Baal, Pieter ; Brouwer, Werner ; Kellerborg, Klas. In: The European Journal of Health Economics. RePEc:spr:eujhec:v:21:y:2020:i:9:d:10.1007_s10198-020-01218-4.

Full description at Econpapers || Download paper

2020Health Economic Models for Metastatic Colorectal Cancer: A Methodological Review. (2020). Gibbs, Peter ; Koopman, Miriam ; Wong, Hui-Li ; Koffijberg, Hendrik ; Vu, Martin ; Degeling, Koen ; Ijzerman, Maarten . In: PharmacoEconomics. RePEc:spr:pharme:v:38:y:2020:i:7:d:10.1007_s40273-020-00908-4.

Full description at Econpapers || Download paper

2020A Bayesian parametric approach to handle missing longitudinal outcome data in trial‐based health economic evaluations. (2020). Daniels, Michael J ; Gabrio, Andrea ; Baio, Gianluca. In: Journal of the Royal Statistical Society Series A. RePEc:bla:jorssa:v:183:y:2020:i:2:p:607-629.

Full description at Econpapers || Download paper

2020Relationship between costs and clinical benefits of new cancer medicines in Australia, France, the UK, and the US. (2020). Mossialos, Elias ; Shearer, Emily ; Salas-Vega, Sebastian . In: Social Science & Medicine. RePEc:eee:socmed:v:258:y:2020:i:c:s0277953620302616.

Full description at Econpapers || Download paper

2020Real World Cost-of-Illness Evidence in Hepatitis C Virus: A systematic review. (2020). Mattingly, Joseph T ; Khokhar, Bilal ; Love, Bryan L. In: PharmacoEconomics. RePEc:spr:pharme:v:38:y:2020:i:9:d:10.1007_s40273-020-00933-3.

Full description at Econpapers || Download paper

2020A Critical Appraisal and Recommendations for Cost-Effectiveness Studies of Poly(ADP-Ribose) Polymerase Inhibitors in Advanced Ovarian Cancer. (2020). McLaurin, Kimmie ; Monberg, Matthew ; Muston, Dominic ; Gao, Wei ; McQueen, Brett R ; Signorovitch, James ; Kalemaj, Iden ; Zhang, SU ; Swallow, Elyse ; Szamreta, Elizabeth ; Hettle, Robert. In: PharmacoEconomics. RePEc:spr:pharme:v:38:y:2020:i:11:d:10.1007_s40273-020-00949-9.

Full description at Econpapers || Download A Dirichlet process mixture model of discrete choice: Comparisons and a case study on preferences for shared automated vehicles. (2020). Vij, Akshay ; Rashidi, Taha H ; Krueger, Rico. In: Journal of choice modelling. RePEc:eee:eejocm:v:36:y:2020:i:c:s1755534520300282.

Full description at Econpapers || Download paper

2020Precision Medicine: Implications for value chains and business models in life sciences. (2020). Denicolai, Stefano ; Previtali, Pietro. In: Technological Forecasting and Social Change. RePEc:eee:tefoso:v:151:y:2020:i:c:s0040162519311023.

Full description at Econpapers || Download paper

2020Managing Uncertainty in AI-Enabled Decision Making and Achieving Sustainability. (2020). Shang, Shari ; Wu, Junyi. In: Sustainability. RePEc:gam:jsusta:v:12:y:2020:i:21:p:8758-:d:432755.

Full description at Econpapers || Download paper

2020Understanding Cross-country Differences in Health Status and Expenditures. (2020). Sopraseuth, Thepthida ; Michaud, Pierre-Carl ; Langot, Francois ; Fonseca, Raquel. In: NBER Working Papers. RePEc:nbr:nberwo:26876.

Full description at Econpapers || Download paper

2020Understanding Cross-country Differences in Health Status and Expenditures. (2020). Sopraseuth, Thepthida ; Langot, Francois ; Fonseca, Raquel ; Michaud, Pierre-Carl. In: Cahiers de recherche / Working Papers. RePEc:rsi:creeic:2004.

Full description at Econpapers || Download paper

2020Understanding Cross-country Differences in Health Status and Expenditures. (2020). Sopraseuth, Thepthida ; Langot, Francois ; Fonseca, Raquel ; Michaud, Pierre-Carl ; Benito, Raquel Fonseca. In: CIRANO Working Papers. RePEc:cir:cirwor:2020s-16.

Full description at Econpapers || Download paper

2020Association between provincial income levels and drug prices in China over the period 2010–2017. (2020). Yang, Xiuyun ; Mossialos, Elias ; Liu, Gordon ; Wouters, Olivier J ; Shi, Wunan. In: Social Science & Medicine. RePEc:eee:socmed:v:263:y:2020:i:c:s0277953620304664.

Full description at Econpapers || Download paper

2020Costs and where to find them: identifying unit costs for health economic evaluations of diabetes in France, Germany and Italy. (2020). Valentine, W J ; Boye, K S ; Norrbacka, K ; Pohlmann, J ; Sapin, H. In: The European Journal of Health Economics. RePEc:spr:eujhec:v:21:y:2020:i:8:d:10.1007_s10198-020-01229-1.

Full description at Econpapers || Download paper

2020Can healthcare choice be predicted using stated preference data?. (2020). Swait, Joffre ; Donkers, Bas ; Bliemer, Michiel ; de Bekker-Grob, E W ; Veldwijk, J ; Bliemer, M. C. J., . In: Social Science & Medicine. RePEc:eee:socmed:v:246:y:2020:i:c:s0277953619307312.

Full description at Econpapers || Download paper

2020Non-monetary numeraires: Varying the payment vehicle in a choice experiment for health interventions in Uganda. (2020). , Poppy ; Mujumbusi, Lazaaro ; Hanley, Nick ; Meginnis, Keila . In: Ecological Economics. RePEc:eee:ecolec:v:170:y:2020:i:c:s0921800919314120.

Full description at Econpapers || Download paper

2020Transforming discrete choice experiment latent scale values for EQ-5D-3L using the visual analogue scale. (2020). Wright, Penny ; Kind, Paul ; Meads, David ; Odwyer, John. In: The European Journal of Health Economics. RePEc:spr:eujhec:v:21:y:2020:i:5:d:10.1007_s10198-020-01173-0.

Full description at Econpapers || Download paper

2020Incorporating discrete choice experiments into policy decisions: Case of designing public long-term care insurance. (2020). Wasi, Nada ; Chandoevwit, Worawan. In: Social Science & Medicine. RePEc:eee:socmed:v:258:y:2020:i:c:s027795362030263x.

Full description at Econpapers || Download paper

2020Reporting Formative Qualitative Research to Support the Development of Quantitative Preference Study Protocols and Corresponding Survey Instruments: Guidelines for Authors and Reviewers. (2020). Peay, Holly ; DiSantostefano, Rachael ; Vass, Caroline ; Beusterien, Kathleen ; Coast, Joanna ; Craig, Benjamin M ; Hollin, Ilene L. In: The Patient: Patient-Centered Outcomes Research. RePEc:spr:patien:v:13:y:2020:i:1:d:10.1007_s40271-019-00401-x.

Full description at Econpapers || Download Empirical Investigation of Ranking vs Best–Worst Scaling Generated Preferences for Attributes of Quality of Life: One and the Same or Differentiable?. (2020). Ratcliffe, Julie ; Lancsar, Emily ; Hutchinson, Claire ; Kaambwa, Billingsley. In: The Patient: Patient-Centered Outcomes Research. RePEc:spr:patien:v:13:y:2020:i:3:d:10.1007_s40271-019-00406-6.

Full description at Econpapers || Download paper

2020Eliciting preferences for outpatient care experiences in Hungary: A discrete choice experiment with a national representative sample. (2020). Baji, Petra ; Gulacsi, Laszlo ; Klazinga, Niek ; Kringos, Dionne ; Pentek, Marta ; Fernandes, Oscar Brito. In: PLOS ONE. RePEc:plo:pone00:0235165.

Full description at Econpapers || Download paper

2020Consumer preference to utilise a mobile health app: A stated preference experiment. (2020). Robinson, Suzanne ; Norman, Richard ; Lim, David. In: PLOS ONE. RePEc:plo:pone00:0229546.

Full description at Econpapers || Download paper

2020Scope elasticity and economic significance in discrete choice experiments. (2020). Grimsrud, Kristine ; Dugstad, Anders ; Navrud, Stle ; Lindhjem, Henrik ; Kipperberg, Gorm. In: Discussion Papers. RePEc:ssb:dispap:942.

Full description at Econpapers || Download paper

2020Patient chosen gap payments in primary care: Predictions of patient acceptability, uptake and willingness to pay from a discrete choice experiment. (2020). Mortimer, D ; Woode, M E ; Mazza, D ; Barton, C ; Epstein, D S. In: Social Science & Medicine. RePEc:eee:socmed:v:263:y:2020:i:c:s0277953620305037.

Full description at Econpapers || Download paper

2020Assessing the impact of excluded attributes on choice in a discrete choice experiment using a follow‐up question. (2020). Sutphin, Jessie ; Mansfield, Carol ; Boeri, Marco. In: Health Economics. RePEc:wly:hlthec:v:29:y:2020:i:10:p:1307-1315.

Full description at Econpapers || Download paper

2020Discrete choice experiments to generate utility values for multi-attribute utility instruments: a systematic review of methods. (2020). Bahrampour, Mina ; Downes, Martin ; Scuffham, Paul A ; Norman, Richard ; Byrnes, Joshua. In: The European Journal of Health Economics. RePEc:spr:eujhec:v:21:y:2020:i:7:d:10.1007_s10198-020-01189-6.

Full description at Econpapers || Download paper

2020Understanding the composite dimensions of the EQ-5D: An experimental approach. (2020). Mullett, Timothy L ; McDonald, Rebecca ; Tsuchiya, Aki. In: Social Science & Medicine. RePEc:eee:socmed:v:265:y:2020:i:c:s0277953620305426.

Full description at Econpapers || Download paper

2020The validation of published utility mapping algorithms: an example of EORTC QLQ-C30 and EQ-5D in non-small cell lung cancer. (2020). Gregory, Joanne ; Hatswell, Anthony J ; Mann, Helen ; Hoyle, Christopher ; Dyer, Matthew . In: Health Economics Review. RePEc:spr:hecrev:v:10:y:2020:i:1:d:10.1186_s13561-020-00269-w.

Full description at Econpapers || Download paper

2020Orphan Drugs of Personalized Medicine in Bulgaria and Their Cost-Effectiveness. (2020). Stoykova-Valcheva, Zhaklin. In: Izvestia Journal of the Union of Scientists - Varna. Economic Sciences Series. RePEc:vra:journl:v:9:y:2020:i:3:p:52-62.

Full description at Econpapers || Download paper

2020After 20 Years of Using Economic Evaluation, Should NICE be Considered a Methods Innovator?. (2020). Palmer, Stephen ; Sculpher, Mark. In: PharmacoEconomics. RePEc:spr:pharme:v:38:y:2020:i:3:d:10.1007_s40273-019-00882-6.

Full description at Econpapers || Download paper

2020Conducting Value for Money Analyses for Non-randomised Interventional Studies Including Service Evaluations: An Educational Review with Recommendations. (2020). Richardson, Gerry ; Lomas, James ; Franklin, Matthew. In: PharmacoEconomics. RePEc:spr:pharme:v:38:y:2020:i:7:d:10.1007_s40273-020-00907-5.

Full description at Econpapers || Download paper

2020Prediction of Claims in Export Credit Finance: A Comparison of Four Machine Learning Techniques. (2020). Krummaker, Simone ; Bartl, Mathias. In: Risks. RePEc:gam:jrisks:v:8:y:2020:i:1:p:22-:d:326934.

Full description at Econpapers || Download paper

2020Social, ethical, and other value judgments in health economics modelling. (2020). Silva, Diego S ; Werker, Gregory R ; Harvard, Stephanie. In: Social Science & Medicine. RePEc:eee:socmed:v:253:y:2020:i:c:s0277953620301945.

Full description at Econpapers || Download paper

2020Presentation and validation of the Abbreviated Self Completion Teen-Addiction Severity Index (ASC T-ASI): A preference-based measure for use in health-economic evaluations. (2020). Roijen, Leona Hakkaart-Van ; Brouwer, Werner ; van Domburgh, Lieke ; Kaminer, Yifrah ; Goorden, Maartje ; Reckers-Droog, Vivian. In: PLOS ONE. RePEc:plo:pone00:0238858.

Full description at Econpapers || Download paper

2020Systematic Literature Review and Critical Appraisal of Health Economic Models Used in Cost-Effectiveness Analyses in Non-Alcoholic Steatohepatitis: Potential for Improvements. (2020). Johansen, Pierre ; Buchholtz, Kristine ; Moreno, Soren Ilsoe ; Bishop, Ryan ; Howard, Daniel . In: PharmacoEconomics. RePEc:spr:pharme:v:38:y:2020:i:5:d:10.1007_s40273-019-00881-7.

Full description at Econpapers || Download paper

Recent citations
Recent citations received in 2020
YearCiting document
2020Health Economics Tools and Precision Medicine: Opportunities and Challenges. (2020). Scott, Ramsey ; Josh, Peterson ; Peter, Neumann ; Jeanne, Mandelblatt ; Anirban, Basu ; David, Veenstra. In: Forum for Health Economics & Policy. RePEc:bpj:fhecpo:v:23:y:2020:i:1:p:14:n:1.

Full description at Econpapers || Download paper

2020Stakeholder-Engaged Derivation of Patient-Informed Value Elements. (2020). Slejko, Julia F ; Zhang, Chengchen ; Hong, Yoon Duk ; Kennedy, Annie ; Caicedo, Juan ; Butler, Beverly ; Dosreis, Susan. In: The Patient: Patient-Centered Outcomes Research. RePEc:spr:patien:v:13:y:2020:i:5:d:10.1007_s40271-020-00433-8.

Full description at Econpapers || Download paper

2020External Validation of the Core Obesity Model to Assess the Cost-Effectiveness of Weight Management Interventions. (2020). Johansen, Pierre ; Foos, Volker ; Olivieri, Anamaria-Vera ; McEwan, Phil ; Lamotte, Mark ; Lopes, Sandra. In: PharmacoEconomics. RePEc:spr:pharme:v:38:y:2020:i:10:d:10.1007_s40273-020-00941-3.

Full description at Econpapers || Download paper

2020Reflections on NICE’s Uptake of New Methods: Past, Present, and the 2020 Review. (2020). Watson, Ian ; Boysen, Meindert. In: PharmacoEconomics. RePEc:spr:pharme:v:38:y:2020:i:3:d:10.1007_s40273-020-00888-5.

Full description at Econpapers || Download paper

2020Feasibility, Validity and Differences in Adolescent and Adult EQ-5D-Y Health State Valuation in Australia and Spain: An Application of Best–Worst Scaling. (2020). Dalziel, Kim ; Rivero-Arias, Oliver ; Norman, Richard ; Gorostiza, Inigo ; Garcia-Lorenzo, Borja ; Catchpool, Max. In: PharmacoEconomics. RePEc:spr:pharme:v:38:y:2020:i:5:d:10.1007_s40273-020-00884-9.

Full description at Econpapers || Download paper

2020Replacing the NCCN’s Blocks with Wheels: How Should Consideration of Societal Spending be Incorporated into Oncology Practice?. (2020). Prasad, Vinay ; Tran, Audrey A. In: PharmacoEconomics. RePEc:spr:pharme:v:38:y:2020:i:7:d:10.1007_s40273-020-00920-8.

Full description at Econpapers || Download paper

2020Does Cost-Effectiveness Analysis Really Need to Abandon the Incremental Cost-Effectiveness Ratio to Embrace Net Benefit?. (2020). Omahony, James F. In: PharmacoEconomics. RePEc:spr:pharme:v:38:y:2020:i:8:d:10.1007_s40273-020-00931-5.

Full description at Econpapers || Download paper

Recent citations received in 2019
YearCiting document
2019Insight of Artificial Intelligence Application in Healthcare. (2019). Kuang, Cedric. In: International Journal of Sciences. RePEc:adm:journl:v:8:y:2019:i:8:p:50-55.

Full description at Econpapers || Download paper

2019Discrete Choice under Oaths. (2019). Watson, Verity ; Shogren, Jason ; Jacquemet, Nicolas ; Luchini, Stephane. In: Université Paris1 Panthéon-Sorbonne (Post-Print and Working Papers). RePEc:hal:cesptp:halshs-02136103.

Full description at Econpapers || Download paper

2019Discrete Choice under Oaths. (2019). Shogren, Jason ; Jacquemet, Nicolas ; Watson, Verity ; Luchini, Stephane. In: Post-Print. RePEc:hal:journl:halshs-02136103.

Full description at Econpapers || Download paper

2019Discrete Choice under Oaths. (2019). Watson, Verity ; Shogren, Jason ; Jacquemet, Nicolas ; Luchini, Stephane. In: Documents de travail du Centre d'Economie de la Sorbonne. RePEc:mse:cesdoc:19007.

Full description at Econpapers || Download paper

2019Public Preferences for Health Gains and Cures: A Discrete Choice Experiment. (2019). Shah, Koonal ; Mott, David ; Hampson, Grace ; Devlin, Nancy. In: Consulting Reports. RePEc:ohe:conrep:002108.

Full description at Econpapers || Download paper

2019Value of information analysis in telehealth for chronic heart failure management. (2019). , Hubertus ; Koymans, Ron ; Buyukkaramikli, Nasuh ; Grustam, Andrija S ; Severens, Johan L. In: PLOS ONE. RePEc:plo:pone00:0218083.

Full description at Econpapers || Download paper

2019The burden of informal caregiving in Hungary, Poland and Slovenia: results from national representative surveys. (2019). Brouwer, Werner ; Baji, Petra ; Pentek, Marta ; Gulacsi, Laszlo ; Zrubka, Zsombor ; Prevolnik-Rupel, Valentina ; Golicki, Dominik. In: The European Journal of Health Economics. RePEc:spr:eujhec:v:20:y:2019:i:1:d:10.1007_s10198-019-01058-x.

Full description at Econpapers || Download paper

2019Achieving Appropriate Model Transparency: Challenges and Potential Solutions for Making Value-Based Decisions in the United States. (2019). Basu, Anirban ; Walton, Surrey M ; Carlson, Josh J ; Ollendorf, Daniel A ; Whittington, Melanie D ; Veenstra, David ; Touchette, Daniel R ; Pearson, Steven D ; McQueen, Brett R ; Campbell, Jonathan D ; Chapman, Richard H. In: PharmacoEconomics. RePEc:spr:pharme:v:37:y:2019:i:11:d:10.1007_s40273-019-00832-2.

Full description at Econpapers || Download Improving Transparency in Decision Models: Current Issues and Potential Solutions. (2019). Caro, Jaime J ; Tappenden, Paul. In: PharmacoEconomics. RePEc:spr:pharme:v:37:y:2019:i:11:d:10.1007_s40273-019-00850-0.

Full description at Econpapers || Download paper

2019Spillover Effects on Caregivers’ and Family Members’ Utility: A Systematic Review of the Literature. (2019). Wittenberg, Eve ; Prosser, Lisa A ; James, Lyndon P. In: PharmacoEconomics. RePEc:spr:pharme:v:37:y:2019:i:4:d:10.1007_s40273-019-00768-7.

Full description at Econpapers || Download paper

2019Advances in Methods and Novel Applications for Measuring Family Spillover Effects of Illness. (2019). Prosser, Lisa A ; Wittenberg, Eve . In: PharmacoEconomics. RePEc:spr:pharme:v:37:y:2019:i:4:d:10.1007_s40273-019-00794-5.

Full description at Econpapers || Download paper

2019Response to ‘Comment on “Cost-Effectiveness of Niraparib Versus Routine Surveillance, Olaparib and Rucaparib for the Maintenance Treatment of Patients with Ovarian Cancer in the United States”â€. (2019). Guy, Holly ; Fisher, Mark ; Walder, Lydia. In: PharmacoEconomics. RePEc:spr:pharme:v:37:y:2019:i:7:d:10.1007_s40273-019-00803-7.

Full description at Econpapers || Download paper

2019U.K. utility weights for the EORTC QLU‐C10D. (2019). Viney, Rosalie ; Street, Deborah J ; Pickard, Simon A ; Cella, David ; Brazier, John E ; Rowen, Donna ; Consortium, The Mauca ; Merciecabebber, Rebecca ; Of, Treatment ; Norman, Richard ; King, Madeleine T ; Revicki, Dennis. In: Health Economics. RePEc:wly:hlthec:v:28:y:2019:i:12:p:1385-1401.

Full description at Econpapers || Download paper

Recent citations received in 2018
YearCiting document
2018Estimating the marginal productivity of the English National Health Service from 2003/04 to 2012/13. (2018). Claxton, Karl ; Martin, Stephen ; Lomas, James. In: Working Papers. RePEc:chy:respap:158cherp.

Full description at Econpapers || Download paper

2018Intended and unintended impacts of price changes for drugs and medical services: Evidence from China. (2018). Fu, Hongqiao ; Yip, Winnie ; Li, Ling. In: Social Science & Medicine. RePEc:eee:socmed:v:211:y:2018:i:c:p:114-122.

Full description at Econpapers || Download paper

2018The long-term costs for treating multiple sclerosis in a 16-year retrospective cohort study in Brazil. (2018). Souza, Kathiaja M ; Pires, Livia Lovato ; Guerra, Augusto Afonso ; de Araujo, Vania Eloisa ; Diniz, Isabela Maia ; Cherchiglia, Mariangela Leal ; Gurgel, Eli Iola ; Alvares, Juliana ; de Assis, Francisco ; Wettermark, Bjorn ; Bennie, Marion ; Godman, Brian. In: PLOS ONE. RePEc:plo:pone00:0199446.

Full description at Econpapers || Download paper

2018Model Structuring for Economic Evaluations of New Health Technologies. (2018). Ali, Hossein Haji ; Karnon, Jonathan ; Bojke, Laura. In: PharmacoEconomics. RePEc:spr:pharme:v:36:y:2018:i:11:d:10.1007_s40273-018-0693-7.

Full description at Econpapers || Download paper

2018Multi-Indication Pricing: Nice in Theory but Can it Work in Practice?. (2018). Mestre-Ferrandiz, Jorge ; Hidalgo-Vega, alvaro ; Alcala, Bleric ; Zozaya, Neboa . In: PharmacoEconomics. RePEc:spr:pharme:v:36:y:2018:i:12:d:10.1007_s40273-018-0716-4.

Full description at Econpapers || Download paper

20183L, 5L, What the L? A NICE Conundrum. (2018). Devlin, Nancy ; Stolk, Elly ; Pickard, Simon A ; Brazier, John. In: PharmacoEconomics. RePEc:spr:pharme:v:36:y:2018:i:6:d:10.1007_s40273-018-0622-9.

Full description at Econpapers || Download paper

2018A Bayesian framework for health economic evaluation in studies with missing data. (2018). Gomes, Manuel ; Carpenter, James R ; Grieve, Richard ; Mason, Alexina J. In: Health Economics. RePEc:wly:hlthec:v:27:y:2018:i:11:p:1670-1683.

Full description at Econpapers || Download paper

2018Missing data in trial‐based cost‐effectiveness analysis: An incomplete journey. (2018). Gomes, Manuel ; Carpenter, James R ; Leurent, Baptiste. In: Health Economics. RePEc:wly:hlthec:v:27:y:2018:i:6:p:1024-1040.

Full description at Econpapers || Download paper

Recent citations received in 2017
YearCiting document
2017Valuing Informal Care in Ireland: Beyond the Traditional Production Boundary. (2017). Hanly, Paul ; Sheerin, Corina. In: The Economic and Social Review. RePEc:eso:journl:v:48:y:2017:i:3:p:337-364.

Full description at Econpapers || Download paper

2017Economic Evaluation of Interventions for Children with Neurodevelopmental Disorders: Opportunities and Challenges. (2017). Lamsal, Ramesh ; Zwicker, Jennifer D. In: Applied Health Economics and Health Policy. RePEc:spr:aphecp:v:15:y:2017:i:6:d:10.1007_s40258-017-0343-9.

Full description at Econpapers || Download paper

2017The Ball is in Your Court: Agenda for Research to Advance the Science of Patient Preferences in the Regulatory Review of Medical Devices in the United States. (2017). Levitan, Bennett ; Christopher, Stephanie ; Jaffe, Ross ; Damiano, Marina G ; Hauber, Brett A. In: The Patient: Patient-Centered Outcomes Research. RePEc:spr:patien:v:10:y:2017:i:5:d:10.1007_s40271-017-0272-6.

Full description at Econpapers || Download paper

2017Discrete Event Simulation-Based Resource Modelling in Health Technology Assessment. (2017). Salleh, Syed ; Dixon, Simon ; Hughes, Ruby ; Brennan, Alan ; Thokala, Praveen. In: PharmacoEconomics. RePEc:spr:pharme:v:35:y:2017:i:10:d:10.1007_s40273-017-0533-1.

Full description at Econpapers || Download paper

2017Response to ‘Comment on “Replicating Health Economic Models: Firm Foundations or a House of Cards?”’. (2017). Bermejo, Inigo ; Youn, Ji-Hee ; Tappenden, Paul. In: PharmacoEconomics. RePEc:spr:pharme:v:35:y:2017:i:11:d:10.1007_s40273-017-0574-5.

Full description at Econpapers || Download paper

2017Comment on “Replicating Health Economic Models: Firm Foundations or a House of Cards?”. (2017). McManus, Emma ; Sach, Tracey. In: PharmacoEconomics. RePEc:spr:pharme:v:35:y:2017:i:11:d:10.1007_s40273-017-0576-3.

Full description at Econpapers || Download paper

2017The Implementation of Managed Entry Agreements in Central and Eastern Europe: Findings and Implications. (2017). Loblova, Olga ; Ferrario, Alessandra ; Kanavos, Panos ; Laidmae, Erki ; Haycox, Alan ; Jakupi, Arianit ; Voncina, Luka ; Hoxha, Iris ; Tomek, Dominik ; Greiit-Kuprijanov, Ieva ; Pomorski, Maciej ; Furst, Jurij ; Petrova, Guenka ; Dimitrova, Maria ; Novakovic, Tanja ; Danko, David ; Meshkov, Dmitry ; Ati, Tarik ; Markovic-Pekovic, Vanda ; Bochenek, Tomasz ; Godman, Brian ; Mardare, Ileana ; Arja, Dina ; Bonanno, Patricia Vella. In: PharmacoEconomics. RePEc:spr:pharme:v:35:y:2017:i:12:d:10.1007_s40273-017-0559-4.

Full description atHeath State Utility Values for Cost-Effectiveness Models. (2017). Karnon, Jonathan. In: PharmacoEconomics. RePEc:spr:pharme:v:35:y:2017:i:1:d:10.1007_s40273-017-0537-x.

Full description at Econpapers || Download paper

2017The Role of Condition-Specific Preference-Based Measures in Health Technology Assessment. (2017). Rowen, Donna ; Zouraq, Ismail Azzabi ; Ara, Roberta ; Brazier, John. In: PharmacoEconomics. RePEc:spr:pharme:v:35:y:2017:i:1:d:10.1007_s40273-017-0546-9.

Full description at Econpapers || Download paper

2017The Identification, Review and Synthesis of Health State Utility Values from the Literature. (2017). Ara, Roberta ; Paisley, Suzy ; Peasgood, Tessa ; Brazier, John. In: PharmacoEconomics. RePEc:spr:pharme:v:35:y:2017:i:1:d:10.1007_s40273-017-0547-8.

Full description at Econpapers || Download paper

2017The Use of Mapping to Estimate Health State Utility Values. (2017). Ara, Roberta ; Mukuria, Clara ; Rowen, Donna. In: PharmacoEconomics. RePEc:spr:pharme:v:35:y:2017:i:1:d:10.1007_s40273-017-0548-7.

Full description at Econpapers || Download paper

2017Recommended Methods for the Collection of Health State Utility Value Evidence in Clinical Studies. (2017). Ara, Roberta ; Young, Tracey ; Brazier, John. In: PharmacoEconomics. RePEc:spr:pharme:v:35:y:2017:i:1:d:10.1007_s40273-017-0549-6.

Full description at Econpapers || Download paper

2017The Use of Health State Utility Values in Decision Models. (2017). Ara, Roberta ; Zouraq, Ismail Azzabi ; Brazier, John. In: PharmacoEconomics. RePEc:spr:pharme:v:35:y:2017:i:1:d:10.1007_s40273-017-0550-0.

Full description at Econpapers || Download paper

2017Response to Letter to the Editor Regarding “Abiraterone Acetate for the Treatment of Chemotherapy-Naïve Metastatic Castration-Resistant Prostate Cancer: An Evidence Review Group Perspective of a NI. (2017). , Bram ; Joore, Manuela A ; Kleijnen, Jos ; Severens, Johan L ; Armstrong, Nigel ; Duffy, Steven ; Deshpande, Sohan ; Asselt, Thea ; Tomini, Florian ; Riemsma, Rob. In: PharmacoEconomics. RePEc:spr:pharme:v:35:y:2017:i:6:d:10.1007_s40273-017-0507-3.

Full description at Econpapers || Download An Investigation of the Overlap Between the ICECAP-A and Five Preference-Based Health-Related Quality of Life Instruments. (2017). Engel, Lidia ; David, ; Lear, Scott A ; Bryan, Stirling ; Mortimer, Duncan. In: PharmacoEconomics. RePEc:spr:pharme:v:35:y:2017:i:7:d:10.1007_s40273-017-0491-7.

Full description at Econpapers || Download paper

2017Ahead of Our Time: Collaboration in Modeling Then and Now. (2017). , Renee ; Ekins, Sean . In: PharmacoEconomics. RePEc:spr:pharme:v:35:y:2017:i:9:d:10.1007_s40273-017-0532-2.

Full description at Econpapers || Download paper